Test Price
2,800 AED✅ Home Collection Available
C3 Deficiency Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
The C3 Deficiency Genetic Test delivers a diagnostic sensitivity of 99.9% through ISO 9001:2015-accredited next-generation sequencing of the complete C3 gene. Our service includes VIP Mobile Phlebotomy with temperature-controlled cold-chain home collection (daily 8 AM–11 PM), followed by a post-result telehealth consultation with a Consultant Medical Geneticist for clinical interpretation. Insurance verification is available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced NGS assay sequences the entire C3 gene to identify pathogenic variants causing complement C3 deficiency, a primary immunodeficiency linked to severe recurrent bacterial infections, autoimmune disorders, and renal disease. The test serves as a definitive molecular diagnostic instrument for symptomatic patients, at-risk family members, and pre-conception carrier screening.
| Feature | Our Test (Premium UAE) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) – full gene sequencing | Targeted mutation panel (limited variants) |
| Diagnostic Sensitivity | 99.9% (all coding regions, splice sites) | ~85% (only known founder mutations) |
| Turnaround Time | 3–4 weeks | 4–6 weeks (often outsourced) |
| Sample Type | Blood (EDTA), extracted DNA, or FTA card (1 drop) | Blood only |
| Regulatory Compliance | DHA‑licensed laboratory, ISO 9001:2015, UAE PDPL | Variable; often non‑accredited |
Physician Insight & Safety Protocols
“In my clinical experience, families facing recurrent infections or unexplained inflammatory conditions carry a heavy burden of uncertainty. Genetic evaluation of the C3 pathway provides a definitive molecular anchor, transforming vague symptoms into a actionable diagnosis. I remind every patient that a genetic result must always be interpreted within the full clinical context by a qualified specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠ Advisory: Clinical Interpretation & Medication Caution
Do not interpret genetic results in isolation. A pathogenic variant in C3 requires correlation with clinical phenotype, family history, and biochemical complement assays. Results must be reviewed by a qualified genetics specialist before any medical decisions are made. Do not discontinue prescribed medication without consulting your doctor; stopping immunosuppressants or antibiotics abruptly can trigger severe disease flares.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with active severe infections requiring acute management should defer testing until clinically stable.
- Exclusion: Individuals unable to provide informed consent, including minors without a legal guardian present (per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Red Flag: Sudden onset of high fever, neck stiffness, photophobia, or difficulty breathing after blood collection → seek emergency care immediately.
- Red Flag: Severe bleeding, rapidly expanding hematoma, or signs of infection at the venipuncture site.
- Red Flag: Any anaphylactic reaction during or shortly after sample collection.
Patient FAQ & Clinical Guidance
1. What is the purpose of the C3 deficiency Genetic Test?
This test detects inherited mutations in the entire C3 gene to confirm primary complement C3 deficiency, enabling early diagnosis and preventive strategies against severe infections.
2. How is the sample collected and is home collection available?
Our ISO-certified cold-chain home collection service sends a certified phlebotomist to draw a blood sample at your convenience, ensuring sample stability and comfort. This VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM.
3. What do the results mean and how will I receive clinical guidance?
A positive result indicates a pathogenic variant contributing to complement deficiency; you will receive a telehealth consultation with our genetic counselor to interpret the findings and plan next steps.
4. Can this test be used for carrier screening or family planning?
Yes, the test can identify heterozygous carriers of C3 mutations, providing valuable information for reproductive planning and family cascade screening.
UAE Regulatory & Data Privacy Adherence
Accredited Laboratory & Data Protection Compliance
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License 1143
All patient data is processed in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic results are encrypted, access-controlled, and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | C3 Deficiency Genetic Test (Full Gene Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – full C3 gene coding regions and splice sites |
| ICD-10-CM Code | D84.1 (Defects in the complement system) |
| LOINC Code | 21643-9 (Genetic analysis of C3 gene) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians